JAMA Neurol: Neurophalmology Symptoms Study in Patients with New Coronary Pneumonia

Typical clinical manifestations of the 2019 coronavirus disease (COVID-19) outbreak include fever, cough, diarrhea and fatigueRecently, researchers examined the neurological manifestations of COVID-19 patientsstudy collected data on patients from three designated COVID-19 special care centers (main urban area, western branch, oncology center) at Wuhan Huazhong University of Science and Technology Hospital between January 16, 2020 and February 19, 2020, for a total of 214 patientsThe patient's neurological symptoms were extracted by electronic medical records and divided into three categories: central nervous system manifestations (dizziness, headache, consciousness disorders, acute cerebrovascular disease, co-stress disorder sympathis0 and epilepsy), peripheral nervous system manifestations (taste disorders, olfactory impairment, vision impairment and nerve pain), and skeletal muscle damage214 COVID-19 patients with an average age of 52.7 years, 87 males (40.7%), 126 (58.9%) in general cases and 88 (41.1%) as severe78 patients (36.4%) had neurologyPatients with severe infections are older, have more underlying diseases, especially high blood pressure, and exhibit fewer typical COVID-19 symptoms, such as fever and cough, than the average patientThe proportion of severely infected people with neurological manifestations was higher, such as acute cerebrovascular disease (5 cases (5.7%)vs 1 case (0.8%), consciousness impairment (13 cases (14.8%) vs 3 cases (2.4%)) and skeletal muscle damage (17 cases (19.3%)) vs6 cases (4.8%))studies suggest that patients with new coronary pneumonia, in addition to respiratory symptoms, are often accompanied by neurological manifestationsDuring the COVID-19 epidemic, be alert to patients with new coronary pneumonia whose main symptoms are not neurologically exhibited